Archived Press Releases – 2019

4D Molecular Therapeutics Announces Presentation of Preclinical Data at the 6th International Update on Fabry Disease and Provides Clinical Update

- Novel vector, 4D-C102, demonstrates superior performance compared to commonly used AAV1, AAV8, and AAV9 - - Fabry product candidate, 4D-310, is on track for anticipated clinical trial initiation in 2020 - Superior transduction of 4DMT’s novel vector, 4D-C102, ...

4D Molecular Therapeutics Expands Leadership Team with Appointments and Promotions of Key Executives

Company adds manufacturing and quality expertise and broad financial, operational and legal experience with the appointments of Fred Kamal, PhD as chief technical officer and head of regulatory and quality and of August Moretti as chief financial officerCompany announces ...